KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Illumina (ILMN) Shares Outstanding (Diluted Average) (2016 - 2025)

Illumina's Shares Outstanding (Diluted Average) history spans 17 years, with the latest figure at $156.0 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 1.89% year-over-year to $156.0 million; the TTM value through Dec 2025 reached $156.0 million, down 1.89%, while the annual FY2025 figure was $156.0 million, 1.89% down from the prior year.
  • Shares Outstanding (Diluted Average) reached $156.0 million in Q4 2025 per ILMN's latest filing, up from $154.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $159.0 million in Q2 2022 to a low of $147.0 million in Q2 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $155.6 million, with a median of $158.0 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): increased 8.16% in 2022, then fell 3.14% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $149.0 million in 2021, then rose by 5.37% to $157.0 million in 2022, then increased by 0.64% to $158.0 million in 2023, then increased by 0.63% to $159.0 million in 2024, then decreased by 1.89% to $156.0 million in 2025.
  • Per Business Quant, the three most recent readings for ILMN's Shares Outstanding (Diluted Average) are $156.0 million (Q4 2025), $154.0 million (Q3 2025), and $158.0 million (Q2 2025).